Inhibition of human ovarian tumor growth by cytokine-induced killer cells

Cited 45 time in scopus
Metadata Downloads
Title
Inhibition of human ovarian tumor growth by cytokine-induced killer cells
Author(s)
Hwan Mook Kim; Jong Soon Kang; J Lim; Song Kyu Park; Kiho Lee; Yeo Dae YoonChang Woo LeeKi Hoon Lee; G Han; K H Yang; Y J Kim; Y Kim; S B Han
Bibliographic Citation
Archives of Pharmacal Research, vol. 30, no. 11, pp. 1464-1470
Publication Year
2007
Abstract
Despite the recent improvement in the treatment of ovarian cancer, this disease is still leading cause of cancer death in women. In this study, the anti-tumor activity of cytokine-induced killer (CIK) cells against human ovarian cancer was evaluated in vitro and in vivo. Although CD3+CD56 + cells were rare in fresh human peripheral blood mononuclear cells, they could expand more than 1,000-fold on day 14 in the presence of anti-CD3 antibody plus IL-2. At an effector-target cell ratio of 30:1, CIK cells destroyed 45% of SK-OV-3 human ovarian cancer cells, which was determined by the 51Cr-release assay. In addition, CIK cells at a dose of 23 million cells per mouse inhibited 73% of SK-OV-3 tumor growth in nude mouse xenograft assay. This study suggests that CIK cells may be used as an adoptive immunotherapy for patients with ovarian cancer.
Keyword
Cytokine-induced killer cellsOvarian cancerAdoptive immunotherapy
ISSN
0253-6269
Publisher
Pharmaceutical Soc Korea
DOI
http://dx.doi.org/10.1007/BF02977372
Type
Article
Appears in Collections:
Ochang Branch Institute > Division of National Bio-Infrastructure > Laboratory Animal Resource & Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.